People Living Beyond 110 Years Have an Unusual Abundance of Killer Immune Cells

🧬 Do killer immune cells contribute to a lifespan beyond 110 years?

Recent research suggests that people who live to 110 years and beyond, known as supercentenarians, may possess a unique immune system that retains its ability to adapt to new challenges even in very advanced age. The study shows that this exceptional age group contains unusually high proportions of specialized immune cells known as CD4 cytotoxic T lymphocytes (CD4 CTLs).

These cells are believed to play an important role in fighting cancer cells in response to various threats, opening new horizons for understanding how the immune system is linked to age and overall health.

🧠 How does the immune system help confront aging?

The immune system changes with age, often losing effectiveness, but this study, published in the journal Cell Reports, offered a new perspective. The researchers analyzed blood samples from different age groups: 70 to 99 years, 100 to 109 years, and those aged 110 years and older.

Contrary to the common expectation of declining immune efficiency, they found a gradual increase in the proportion of CD4 CTLs as follows:

• 4% in the 70-99 age group
• 9.6% in the 100-109 age group
• 17.6% at age 110 years and older

This increase suggests the continued adaptability of the immune system to surrounding factors despite aging, which runs counter to the traditional view that immunity inevitably declines over time.

🩺 Clonal expansion of killer immune cells

The study explained that these immune cells multiply through a process called clonal expansion, in which the original cell creates many copies of itself in response to a specific threat. Among the older adults participating in the study, the largest single clone group could account for 33.3%, with a notable case in one individual whose lone clone reached 53.8% of CD4 CTLs.

The significance here is that this expansion indicates that the immune system is not only adapting, but also remaining alert and highly responsive to potential threats, which may be associated with chronic diseases or abnormal cellular changes.

🧪 The relationship between CD4 CTLs and cancer

When the researchers compared the receptor sequences of these immune cells with a dedicated database, they found matching relationships with cells identified in patients with different cancers such as lung, breast, and liver. Notably, the participants who reached ages above 110 were not affected by these cancers.

This observation suggests the possibility that these immune cells recognize and respond early to targets associated with cancerous or abnormal cells, which may help maintain immune health and indirectly protect the body from the development of some diseases.

🌱 How do these findings affect our understanding of healthy aging?

The lead researcher, Kosuke Hashimoto, acknowledges that the presence of these cells does not necessarily mean complete protection from cancer or directly making individuals live longer. Nevertheless, they support the idea that the immune system is not merely a system that loses its functions over time, but one that continues to learn and adapt to the challenges that accompany aging.

This study suggests that renewed and enhanced immune responses in older adults may contribute to exceptional longevity and provide sustainable health in later stages of life.

🧬 Future research steps

The research team plans to study the behavior of CD4 CTLs in different body tissues rather than relying only on blood samples. This could help clarify the functions of these immune cells more precisely, especially where immune challenges such as tumors or inflammation arise.

Focusing on these cells may eventually yield a better understanding of the mechanisms that preserve the body’s health with age, and may open new horizons in research fields related to resistance to age-associated diseases.

🧠 Article summary

The findings from studies of supercentenarians reveal the role of CD4 cytotoxic T lymphocytes in sustaining the immune system’s response to various challenges, especially at ages beyond 110 years. These cells, known for their ability to kill abnormal cells, expand remarkably through clonal proliferation, helping maintain effective immunity against cellular changes and possible diseases. The results show that immune aging is not necessarily a decline, but may involve continuous adaptation, prompting further research into the mechanisms of immunity associated with longevity.

📚 Related articles

📄

🧬 Challenges of Traditional Vision Correction

2026/09/07

USC scientists achieve continuous production of cancer-resistant immune cells

2026/09/07

Increasing bean and soy intake lowers the risk of high blood pressure by about 30%

2026/09/07